COVID-19 UPDATE

Contact

BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

Events & Presentations

Past Events

BDSI First Quarter 2020 Financial Results Call and Webcast

May 7, 2020 at 4:30 PM EDT

Listen to webcast

Supporting Materials

View Presentation 586.1 KB

BDSI Fourth Quarter 2019 Financial Results Call and Webcast

Mar 12, 2020 at 4:30 PM EDT

Listen to webcast

Supporting Materials

View Presentation 603.9 KB

Piper Jaffray 31st Annual Healthcare Conference

Dec 4, 2019 at 12:00 PM EST

Jefferies Global Healthcare Conference

Nov 20, 2019 at 5:20 PM GMT

Listen to webcast

Supporting Materials

View Presentation 1.4 MB

BDSI Third Quarter 2019 Financial Results Call and Webcast

Nov 12, 2019 at 4:30 PM EST

Listen to webcast

Supporting Materials

View Presentation 11 MB

Cantor Fitzgerald 2019 Healthcare Conference

Oct 3, 2019 at 1:15 PM EDT

Listen to webcast

Ladenburg Thalmann 2019 Healthcare Conference

Sep 24, 2019 at 9:30 AM EDT

Listen to webcast

H.C. Wainwright 21st Annual Global Investment Conference

Sep 9, 2019 at 11:15 AM EDT

Listen to webcast

2019 Wells Fargo Healthcare Conference

Sep 5, 2019 at 10:55 AM EDT

Listen to webcast

Recent BDSI News

BioDelivery Sciences Appoints Jeff Bailey Interim CEO May 11, 2020

RALEIGH, N.C. , May 11, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that Jeffrey A. ...

BioDelivery Sciences Reports Strong Q1 2020 Results May 7, 2020

First Quarter Total Company Net Sales Increased 94% versus Prior Year to $38.3 Million First Quarter BELBUCA® Net Sales Increased 79% versus Prior Year to $33.5 Million Conference Call and Webcast Scheduled for 4:30 PM EST Today RALEIGH, N.C. , May 07, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences ...

BioDelivery Sciences to Report First Quarter 2020 Financial Results on May 7, 2020 April 28, 2020

RALEIGH, N.C. , April 28, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its first quarter 2020 ...

More news

More events

Stay Connected

Stay up to date on the latest news

Get started now